Study to Evaluate a Single Intranasal Dose of STI-2099 (COVI-DROPS™) in Outpatient Adults With COVID-19 (US)
Public ClinicalTrials.gov record NCT04906694. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Placebo-controlled Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Intranasal STI-2099 (COVI-DROPS™) in Outpatient Adults With COVID-19
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a double-blind study designed to investigate the efficacy, safety and PK of a single dose of COVI-DROPS or matched placebo in outpatient adults who have tested positive for COVID-19 and are either asymptomatic or have mild symptoms.
Study identification
- NCT ID
- NCT04906694
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 97 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 16, 2021 (Actual)
- Primary completion
- Jan 13, 2022 (Actual)
- Completion
- Jan 13, 2022 (Actual)
- Last update posted
- Feb 3, 2022
2021 – 2022
United States locations
- U.S. sites
- 18
- U.S. states
- 10
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Future Innovative Treatments, LLC | Colorado Springs | Colorado | 80907 | — |
| Clinical Neuroscience dba CNS Healthcare | Jacksonville | Florida | 32256 | — |
| Med-Care Research | Miami | Florida | 33165 | — |
| Clinical Neuroscience Solutions Healthcare | Orlando | Florida | 32801 | — |
| Precision Research Center | Tampa | Florida | 33614 | — |
| Clinical Site Partners, Inc | Winter Park | Florida | 32789 | — |
| Randomize Now | Peachtree City | Georgia | 30269 | — |
| Revival Research Institute | Dearborn | Michigan | 48126 | — |
| Quality Clinical Research | Omaha | Nebraska | 68114 | — |
| Remington Davis | Columbus | Ohio | 43215 | — |
| Cyn3rgy Research | Gresham | Oregon | 97030 | — |
| WR-ClinSearch | Chattanooga | Tennessee | 37421 | — |
| Advanced Medical Trials | Georgetown | Texas | 78628 | — |
| Precision Comprehensive Clinical Research Solutions | Grapevine | Texas | 76051 | — |
| Centex Studies Inc. Houston | Houston | Texas | 77062 | — |
| LinQ | Pearland | Texas | 77584 | — |
| Epic Research | Red Oak | Texas | 75154 | — |
| Infectious Diseases Associates of Central Virginia | Lynchburg | Virginia | 24501 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04906694, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 3, 2022 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04906694 live on ClinicalTrials.gov.